{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:20:09Z","timestamp":1793625609932,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006383","name":"Sy\u00f6p\u00e4j\u00e4rjest\u00f6t","doi-asserted-by":"publisher","award":["4706116"],"award-info":[{"award-number":["4706116"]}],"id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["331151"],"award-info":[{"award-number":["331151"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015735","name":"Helsinki Institute of Life Science, Helsingin Yliopisto","doi-asserted-by":"publisher","award":["797011004"],"award-info":[{"award-number":["797011004"]}],"id":[{"id":"10.13039\/100015735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["4705796"],"award-info":[{"award-number":["4705796"]}],"id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["4706235"],"award-info":[{"award-number":["4706235"]}],"id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"University Medical Centre Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioactmat.2024.11.006","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T09:46:27Z","timestamp":1732009587000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches"],"prefix":"10.1016","volume":"45","author":[{"given":"Carmine","family":"D'Amico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manlio","family":"Fusciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"D'Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7691-4067","authenticated-orcid":false,"given":"Paolo","family":"Bottega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milda","family":"Saklauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Cerioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Elbadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-2064","authenticated-orcid":false,"given":"Marianna","family":"Kemell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cerullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-6309","authenticated-orcid":false,"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2024.11.006_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2020.09.038","article-title":"Personalized cancer vaccines: clinical landscape, challenges, and opportunities","volume":"29","author":"Shemesh","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11523-020-00788-w","article-title":"Vaccine therapies for cancer: then and now","volume":"16","author":"Morse","year":"2021","journal-title":"Targeted Oncol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib5","article-title":"Enhanced cancer immunotherapy by microneedle patch-assisted delivery of HBc VLPs based cancer vaccine","volume":"24","author":"Guo","year":"2021","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.biomaterials.2007.12.048","article-title":"Dissolving microneedles for transdermal drug delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.addr.2003.10.023","article-title":"Microneedles for transdermal drug delivery","volume":"56","author":"Prausnitz","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib9","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1016\/j.vaccine.2010.05.055","article-title":"Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin","volume":"28","author":"Pearton","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib10","doi-asserted-by":"crossref","first-page":"5410","DOI":"10.1016\/j.vaccine.2021.07.064","article-title":"Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles","volume":"39","author":"Stinson","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302410","article-title":"Exploiting unique features of microneedles to modulate immunity","volume":"35","author":"Edwards","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202200905","article-title":"A single\u2010administration microneedle skin patch for multi\u2010burst release of vaccine against SARS\u2010CoV\u20102","volume":"8","author":"Tran","year":"2023","journal-title":"Adv Materials Technologies"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib13","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/acsbiomaterials.9b00961","article-title":"Biodegradable microneedle patch delivering antigenic peptide\u2013hyaluronate conjugate for cancer immunotherapy","volume":"5","author":"Kim","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib14","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1016\/j.vaccine.2022.10.026","article-title":"Prevalence of pain and fear as barriers to vaccination in children \u2013 systematic review and meta-analysis","volume":"40","author":"Taddio","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2015.11.019","article-title":"Microneedle patches for vaccination in developing countries","volume":"240","author":"Arya","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/1061186X.2016.1200589","article-title":"Considerations in the use of microneedles: pain, convenience, anxiety and safety","volume":"25","author":"Jeong","year":"2017","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib17","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2014.01.076","article-title":"Microneedle patches: usability and acceptability for self-vaccination against influenza","volume":"32","author":"Norman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib18","article-title":"The promise of microneedle technologies for drug delivery","author":"Donnelly","year":"2023","journal-title":"Drug Deliv. and Transl. Res."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826164","article-title":"Peptides-coated oncolytic vaccines for cancer personalized medicine","volume":"13","author":"Feola","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1568009617666170502152352","article-title":"Cancer-targeted oncolytic adenoviruses for modulation of the immune system","volume":"18","author":"Cerullo","year":"2018","journal-title":"CCDT"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.omto.2021.02.006","article-title":"Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform","volume":"20","author":"Yl\u00f6sm\u00e4ki","year":"2021","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib22","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1016\/j.actbio.2013.04.045","article-title":"Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications","volume":"9","author":"Sun","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/09205063.2022.2155778","article-title":"PVP-microneedle array for drug delivery: mechanical insight, biodegradation, and recent advances","volume":"34","author":"Mangang","year":"2023","journal-title":"Journal of Biomaterials Science"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202300138","article-title":"Double\u2010layered polyvinylpyrrolidone\u2013poly(methyl vinyl ether\u2010 alt \u2010maleic acid)\u2010based microneedles to deliver meloxicam: an in vitro, in vivo, and short\u2010term stability evaluation study","volume":"6","author":"D'Amico","year":"2023","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib25","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.molpharmaceut.4c00065","article-title":"Transdermal delivery of pramipexole using microneedle technology for the potential treatment of Parkinson's disease","volume":"21","author":"McGuckin","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119580","article-title":"Development and characterisation of novel poly (vinyl alcohol)\/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate","volume":"586","author":"Tekko","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib27","article-title":"Potential of trehalose and sucrose-raffinose combination instead of sucrose applied to the cytarabine\/daunorubicin co-loaded lyophilized liposome: Investigation on the protective effect and mechanism of various lyoprotectants","volume":"92","author":"Liu","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/btm2.10103","article-title":"Self\u2010healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches","volume":"4","author":"Mazzara","year":"2019","journal-title":"Bioengineering & Transla Med"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jps.10340","article-title":"Structural stability of adenovirus type 5","volume":"92","author":"Rexroad","year":"2003","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fimmu.2019.00009","article-title":"Are conventional type 1 dendritic cells critical for protective antitumor immunity and how?","volume":"10","author":"Cancel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2014.8","article-title":"Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy","volume":"1","author":"Farzad","year":"2014","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib34","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/mt.2012.137","article-title":"An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance","volume":"20","author":"Cerullo","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.omtm.2021.01.014","article-title":"GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses","volume":"20","author":"Hamdan","year":"2021","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11095-012-0946-7","article-title":"Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum","volume":"30","author":"Andrews","year":"2013","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib38","article-title":"Skin biomechanics: breaking the dermal barriers with microneedles","volume":"1","author":"Ali","year":"2022","journal-title":"Nano TransMed"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib39","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/eji.1830211136","article-title":"Exact prediction of a natural T cell epitope","volume":"21","author":"R\u00f6tzschke","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120491","article-title":"Trends of microneedle technology in the scientific literature, patents, clinical trials and internet activity","volume":"267","author":"Ingrole","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib41","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(24)00532-4","article-title":"A measles and rubella vaccine microneedle patch in the Gambia: a phase 1\/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial","volume":"403","author":"Adigweme","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib42","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41467-022-30861-z","article-title":"Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8+ T cells","volume":"13","author":"Mizukoshi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2020.12.019","article-title":"Microneedles for painless transdermal immunotherapeutic applications","volume":"330","author":"Amani","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature25144","article-title":"Effector CD8 T cells dedifferentiate into long-lived memory cells","volume":"552","author":"Youngblood","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41422-020-0277-x","article-title":"The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity","volume":"30","author":"Schnell","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2019.04.003","article-title":"Antigen presentation by dendritic cells for B cell activation","volume":"58","author":"Heath","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib48","article-title":"Transdermal microneedles alleviated rheumatoid arthritis by inducing immune tolerance via skin\u2010resident antigen presenting cells","volume":"20","author":"Zhao","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jconrel.2023.04.031","article-title":"Microneedle-assisted vaccination combined with autophagy regulation for antitumor immunotherapy","volume":"357","author":"Yang","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202201952","article-title":"Differential dual\u2010release bilayer microneedles loaded with aluminum adjuvants as a safe and effective vaccine platform","volume":"32","author":"Bian","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib51","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-20-2564","article-title":"Type I IFN activating type I dendritic cells for antitumor immunity","volume":"27","author":"Liang","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib52","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129926","article-title":"PeptiVAX: a new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines","volume":"262","author":"Feola","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib55","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/17425247.2023.2201494","article-title":"Exploring new frontiers in drug delivery with minimally invasive microneedles: fabrication techniques, biomedical applications, and regulatory aspects","volume":"20","author":"Sultana","year":"2023","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4155\/tde-2017-0028","article-title":"How can microneedles overcome challenges facing transdermal drug delivery?","volume":"8","author":"Donnelly","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bioactmat.2024.11.006_bib57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","article-title":"Dissolving microneedles: applications and growing therapeutic potential","volume":"348","author":"Sartawi","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2024.11.006_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106392","article-title":"The role of 3D printing technology in microengineering of microneedles","volume":"18","author":"Detamornrat","year":"2022","journal-title":"Small"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X24004900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:21:10Z","timestamp":1770024070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X24004900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"alternative-id":["S2452199X24004900"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.11.006","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2024.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}